QUVIVIQ 50 mg film-coated tablets

Multi-center, double-blind, randomized, placebo-controlled, parallel-group, polysomnography, dosefinding study assessing the efficacy, safety, and pharmacokinetics of multiple-dose oral administration of daridorexant in pediatric subjects aged 10 to < 18 years with insomnia disorder

A multi-center, double-blind, randomized, placebo-controlled, 2-way cross-over post approval study to investigate the efficacy of daridorexant in subjects with insomnia and comorbid nocturia

Daridorexant to treat insomnia in patients with mild cognitive impairment and mild to moderate Alzheimer disease.

DARIdorexant efficacy on the COGnitive performance in patients with chronic insomnia disorder. DARI-COG Study